Πίσω
Πίσω

02-07-2022

73 V. Koshkin - Antibody drug conjugates and targeted therapies in urothelial cancer

73 V. Koshkin - Antibody drug conjugates and targeted therap...

74 T. Zhang - Updates in the Peri-operative Management of Renal Cell Carcinoma

74 T. Zhang - Updates in the Peri-operative Management of Re...

75 S. Pal - Optimal Treatment Algorithms in Advanced Renal Cell Carcinoma (1st line and salvage)

75 S. Pal - Optimal Treatment Algorithms in Advanced Renal C...

76 D. Carozza - The critical role of Palliative Care and Hospice

76 D. Carozza - The critical role of Palliative Care and Hos...

76 F. Meric-Bernstam - Organizing a Phase I Clinical Trial Program

76 F. Meric-Bernstam - Organizing a Phase I Clinical Trial P...

77 C. Pritchard - Somatic Tumor Genomic Testing

77 C. Pritchard - Somatic Tumor Genomic Testing

78 M. Dubard-Gault - Germline Testing in Oncology

78 M. Dubard-Gault - Germline Testing in Oncology

79 M. Liu - Circulating tumor DNA: Implications in Cancer Screening

79 M. Liu - Circulating tumor DNA: Implications in Cancer Sc...

80 Α. Wang - Future perspectives in precision and personalized radiation oncology

80 Α. Wang - Future perspectives in precision and personaliz...

82 B. Rini - Βiomarkers and future of personalized therapy in RCC

82 B. Rini - Βiomarkers and future of personalized therapy i...